Camptosar and blood bilirubin increased Patient Reports March 19, 2010

Camptosar Side Effects Report #5123556-2
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 70 years of age, weighting 161.0 lb, was diagnosed with oesophageal carcinoma and was treated with Camptosar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, dehydration, diarrhoea, disease progression, feeling abnormal, hypotension, metabolic acidosis, nausea . Camptosar dosage: (125 MG/M2. During the same period patient was treated with MITOMYCIN, PROSCAR, ATROPINE, DEXAMETHASONE, ONDANSETRON, LOPERAMIDE, APREPITANT. Patient died on 12/11/2005.

Camptosar Side Effects Report #4615000-6
Camptosar side effect was reported by a Health Professional from on Mar 07, 2005. Male patient, 44 years of age, weighting 143.3 lb, was diagnosed with metastatic neoplasm and was treated with Camptosar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, coagulopathy, disease progression, faecal occult blood positive, gastrointestinal haemorrhage. Camptosar dosage: unknown. During the same period patient was treated with GEMCITABINE, GEFITINIB, CLOPIDOGREL BISULPHATE, PROMETHAZINE HYDROCHLORIDE, OXYCODONE, ISOSORBIDE MONONITRATE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 08/10/2004.

Camptosar Side Effects Report #5123555-0
Camptosar side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2005. Male patient, 38 years of age, was diagnosed with colon cancer metastatic and was treated with Camptosar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, fear, malaise, white blood cell count decreased. Camptosar dosage: 125 MG/M2 (WEEKLY). Patient recovered.

Camptosar Side Effects Report #4949005-2
Camptosar side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Female patient, 75 years of age, weighting 122.0 lb, was diagnosed with breast cancer , ascites and was treated with Camptosar. After drug was administered, patient experienced the following side effects: ascites, asthenia, blood bilirubin increased, diarrhoea, hepatotoxicity, jaundice , lethargy, metastases to gastrointestinal tract, metastases to liver. Camptosar dosage: 97 MG (97 MG, CYCLIC). During the same period patient was treated with ALDACTONE, XELODA, COMPAZINE, POTASSIUM. Patient recovered.


Camptosar Side Effects Report #4949193-8
Camptosar side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Female patient, 75 years of age, weighting 122.0 lb, was diagnosed with breast cancer , ascites and was treated with Camptosar. After drug was administered, patient experienced the following side effects: asthenia, blood bilirubin increased, diarrhoea, hepatotoxicity, jaundice , lethargy, metastases to large intestine, platelet count decreased, pyrexia. Camptosar dosage: 97 MG (97 MG, CYCLIC). During the same period patient was treated with ALDACTONE, XELODA, COMPAZINE, POTASSIUM. Patient recovered.

Camptosar Side Effects Report #5143085-X
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2006. Male patient, weighting 120.2 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , activated partial thromboplastin time prolonged, alanine aminotransferase increased, ammonia increased, arrhythmia , aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased. Camptosar dosage: 425 MG. During the same period patient was treated with TEMOZOLOMIDE, VINCRISTINE SULPHATE, BACTRIM, CELEXA, DECADRON, FENTANYL TRANSDERMAL SYSTEM, NEURONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Camptosar Side Effects Report #5151048-3
Camptosar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, weighting 120.2 lb, was treated with Camptosar. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , activated partial thromboplastin time prolonged, alanine aminotransferase increased, ammonia increased, arrhythmia , aspartate aminotransferase increased, blood bilirubin increased, blood sodium decreased. Camptosar dosage: 425 MG. During the same period patient was treated with TEMOZOLOMIDE, VINCRISTINE SULPHATE, BACTRIM, CELEXA, DECADRON, FENTANYL TRANSDERMAL SYSTEM, NEURONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.